AMD Screening Transformed: How I-SCREEN Uses AI to Protect Vision Earlier

Age-related macular degeneration (AMD) is one of the leading causes of vision loss in Europe, affecting nearly 200 million people globally. Driven by ageing, genetics, and lifestyle factors, the disease progressively damages the macula, the part of the retina responsible for sharp, central vision. What makes AMD particularly challenging is how silently it develops. By the time patients notice blurred vision or dark spots, irreversible damage may have already occurred, closing the window for effective treatment. This is why early detection by primary eye care professionals such as optometrists is so critical, and why I-SCREEN exists.

Smarter screening, powered by AI

I-SCREEN integrates AI-powered risk prediction tools directly into the routine workflows of optometry practices. Using high-resolution retinal imaging, the technology identifies early signs of AMD before symptoms appear, predicts each patient's individual risk of progression to advanced disease, and supports more informed and personalised referral decisions.

The result is screening that is faster, more consistent, and more accessible, especially for those at highest risk.

Bridging optometry and ophthalmology

Beyond the technology itself, I-SCREEN is strengthening the relationship between optometrists and ophthalmology clinics. By fostering a shared care model built on superior data, the project enhances clinical collaboration and ensures patients are seen by the right specialist at the right time. Community practices across Europe are already contributing to this work through routine screening, bringing research and frontline care together in a meaningful way.

A new standard for vision care

I-SCREEN represents an opportunity to be part of a new generation of eye care innovation, one that combines expert clinical judgment with the power of AI to protect sight earlier, for more people, across Europe.

Watch our video to find out more about how I-SCREEN is transforming AMD care across Europe.